{"version":"1.0","type":"link","title":"Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation.","author_name":"Fan J 외","author_url":"https://prs-insight.online/author/Fan%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/82952","thumbnail_width":1200,"thumbnail_height":630}